| Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc |
| Journal website http://www.cardiologyres.org |
Original Article
Volume 11, Number 5, October 2020, pages 311-318
Low-Density Lipoprotein Cholesterol Targets in Patients With Coronary Heart Disease in Extremadura (Spain): LYNX Registry
Figure

Tables
| Clinical variables | Results |
|---|---|
| CHD: coronary heart disease; CVD: cardiovascular disease. | |
| Age (years) | 65.6 ± 12.1 |
| Age of onset of CHD (years) | 59.4 ± 12.0 |
| Women (%) | 19.3 |
| Weight (kg) | 78.1 ± 14.7 |
| Size (cm) | 165.0 ± 9.4 |
| Body mass index (BMI) (kg/m2) | 28.6 ± 4.3 |
| Nutritional condition | |
| Low weight (BMI < 18.4) (%) | 0.2 |
| Normal weight (BMI 18.5 - 24.9) (%) | 18.1 |
| Overweight (BMI 25 - 29.9) (%) | 48.1 |
| Obesity (BMI > 30) (%) | 33.6 |
| Waist circumference (cm) | 101.7 ± 10.6 |
| > 102 in man (%) | 46 |
| > 88 in women (%) | 90.7 |
| Active smoker (%) | 15.3 |
| Arterial hypertension (%) | 63.6 |
| Diabetes mellitus (%) | 38.7 |
| Dyslipidemia (%) | 66.6 |
| Family history of premature CVD (%) | 37.9 |
| Peripheral artery disease (%) | 10.4 |
| Cerebrovascular disease (%) | 7.1 |
| Atrial fibrillation (%) | 12.6 |
| HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; HbA1c: glycosylated hemoglobin. | |
| Total cholesterol (mg/dL) | 139.2 ± 31.1 |
| LDL-C (mg/dL) | 68.3 ± 24.5 |
| HDL-C (mg/dL) | 47.3 ± 13.9 |
| Triglycerides (mg/dL) | 119.3 ± 69.3 |
| Non-HDL cholesterol (mg/dL) | 91.9 ± 28.3 |
| Creatinine (mg/dL) | 1.1 ± 0.7 |
| Glucose (mg/dL) | 112.4 ± 34.6 |
| HbA1c (%) | 6.1 ± 1.0 |
| OR (95% CI) | P | |
|---|---|---|
| Statistical C = 0.67 (0.63 - 0.71). Hosmer-Lemeshow calibration P = 0.23. OR: odds ratio; CI: confidence interval; LDL-C: low-density lipoprotein cholesterol. | ||
| Female sex | 1.7 (1.12 - 2.48) | 0.01 |
| Diabetes | 0.7 (0.50 - 0.96) | 0.03 |
| Active smoker | 2.0 (1.29 - 3.11) | 0.002 |
| Multivessel CHD | 1.5 (1.03 - 2.16) | 0.03 |
| High-intensity statins | 0.7 (0.46 - 0.92) | 0.01 |
| Ezetimibe | 0.6 (0.45 - 0.91) | 0.01 |
| Atrial fibrillation | 1.9 (1.14 - 3.02) | 0.01 |